Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 3.02, 5.03, 8.01, 9.01 · 8-K

MARPAI INC

Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other Events

Item 1.01 Entry into a Material Definitive Agreement. On July 29, 2026, Marpai, Inc. (the “Company”) entered into securities purchase agreements (each, a “Securities Purchase Agreement”) with accredited investors relating to an offering (the “Offering”) and the sale of an aggregate of 12,100 shares of newly designated Series A Preferred Stock (the “Preferred Stock”) at a purchase price of $1,000 f…

Filed Jul 31, 2026Accepted Jul 31, 2026, 5:29 PM EDTCIK 1844392Accession 0001213900-26-084129
Share

Company context

Marpai, Inc. (OTCQX: MRAI) is a healthcare technology company providing Third-Party Administration and Pharmacy Benefit Management services. The Company supports self-funded employer health plans with solutions designed to improve plan performance, manage healthcare costs, and enhance member outcomes.

Current securities

Historical securities (2)

Recent company filings

  1. DEF 14A filingOct 23, 2026
  2. SCHEDULE 13D/A - filed by Mitchell Calvin Steven regarding Marpai, Inc.Aug 13, 2026
  3. SCHEDULE 13D - filed by Mitchell Calvin Steven regarding Marpai, Inc.Aug 13, 2026
  4. 10-Q filingAug 13, 2026
  5. Entry into a Material Definitive Agreement · Other EventsJul 20, 2026

Registered securities in this filing

MARPAI, INC. · 8-K · Filed 2026-07-31

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Class A Common Stock, par value $0.0001 per share

Symbol
MRAI
Exchange
Not supplied
Classification
COMMON
Filing context

Context: AsOf2026-07-29

Dimensions: Not supplied

Accession 000121390026084129 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 3.02, 5.03, 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement. On July 29, 2026, Marpai, Inc. (the “Company”) entered into securities purchase agreements (each, a “Securities Purchase Agreement”) with accredited investors relating to an offering (the “Offering”) and the sale of an aggregate of 12,100 shares of newly designated Series A Preferred Stock (the “Preferred Stock”) at a purchase price of $1,000 for each share of Preferred Stock. The aggregate gross proceeds to the Company from the Offering are expected to be approximately $12,100,000. The initial closing of the Offering is expected to occur on or about July 31, 2026 (the “Initial Closing”). On July 31, 2026, the Company filed the Certificate of Designation of Preferences Rights and Limitations of Series A Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware. Each share of Preferred Stock is convertible at the option of the holder, subject to certain beneficial ownership limitation as set forth in the Certificate of Designation, into such number of Common Stock, which shall be determined by dividing the stated value of $1,000 by the conversion price of $1.00, subject to certain adjustments in the event of stock splits, stock dividends, and similar transactions. In addition, each share of Preferred Stock will automatically convert into Common Stock upon a qualified public offering or a vote of sixty percent (60%) of the holders of Preferred Stock. The Preferred Stock also provides that upon a liquidity event or a conversion to Common Stock, holders of the Preferred Stock will be entitled to receive an eight percent (8%) dividend payable in Common Stock. The Preferred Stock will vote together with the Common Stock as a single class on all matters submitted to the vote of the stockholders of the Company on an as-converted basis, except as otherwise required by law. Upon any liquidation, dissolution or winding-up of the Company, after the satisfaction in full of the debts of the Company and payment of the liquidation preference to the Senior Securities (as defined in the Certificate of Designation), holders of Preferred Stock shall be entitled to be paid, on a pari passu basis with the payment of any liquidation preference afforded to holders of any Parity Securities (as defined in the Certificate of Designation) out of (but only to the extent) the assets of the Company that are legally available for distribution to its stockholders, in the manner described in the Certificate of Designation. In conjunction with the execution of the Purchase Agreements, the Company and the Mitchell Family Trust II, who acted as the lead investor in the Offering, entered into a board observer agreement (the “Board Observer Agreement”), pursuant to which Steve Mitchell will serve as an observer to the board of directors of the Company. Pursuant to the Board Observer Agreement, Mr. Mitchell will be entitled to serve as a board observer for a period of two (2) years, provided that the lead investor continues to own at least 3,000 shares of Preferred Stock. Pursuant to the terms of the Purchase Agreement, the Company agreed to file a registration statement within sixty (60) calendar days of the closing of the offering, and use commercially reasonable efforts to cause such registration statement to become effective within ninety (90) days following closing date. In addition, pursuant to the Purchase Agreement, the Company agreed to provide any purchaser who continues to own such number of shares of Preferred Stock equal to ten percent (10%) of the Company’s issued and outstanding shares of Common Stock, such purchaser shall be entitled to receive certain information rights. In addition, for a period of twenty-four (24) months, each purchaser who purchased at least fifty (50) shares of Preferred Stock will be entitled to certain rights to participate in future equity offerings of the Company. Subject to certain conditions, the Purchase Agreement also provides the purchasers of Preferred Stock with most-favored nation treatment, giving them the right to amend their securities if the Company issues securities with more favorable terms while the investor’s securities are outstanding, subject to certain exceptions and limitations. Such most-favored nation treatment expires upon the earlier of the Company completing an underwritten public offering of common stock at a price per share equal to 100% of the initial Conversion Price of the Preferred Stock for gross proceeds of at least $5 million, and the date or the occurrence of an event specified by the vote or written consent of the holders then holding at least 60% of the then-outstanding shares of Preferred Stock. The Purchase Agreements contain representations and warranties that the parties made to the others in the context of all of the terms and conditions of that agreement and in the context of the specific relationship between the parties. The provisions of such agreements, including the representations and warranties contained therein, are not for the benefit of any party other than the parties to such agreements and are not intended as documents for investors and the public to obtain factual information about the current state of affairs of the parties to that agreement. Rather, investors and the public should look to other disclosures contained in the Company’s filings with the U.S. Securities and Exchange Commission. The securities to be issued in the Offering are exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder. The securities have not been registered under the Securities Act and may not be resold in the United States absent registration or an exemption from registration. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The forgoing description of the Certificate of Designation, the Purchase Agreement and the Board Observer Agreement are qualified by reference to the full text of these documents, copies of which are filed as Exhibit 3.1, Exhibit 10.1, and Exhibit 10.2 respectively, to this Current Report on Form 8-K.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item 3.02 Unregistered Sales of Equity Securities. The response to this item is included in Item 1.01, Entry into a Material Definitive Agreement, and is incorporated herein in its entirety.
Item 5.03Item 5.03 - Amendments to Articles/Bylaws
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Certificate of Incorporation of the Company authorizes the issuance of up to 2,000,000 shares of preferred stock and further authorizes the Board of the Company to fix and determine the designation, preferences, conversion rights, or other rights, including voting rights, qualifications, limitations, or restrictions of the preferred stock. On July 31, 2026, the Company filed the Certificate of Designation, designating 12,100 shares of Preferred Stock in connection with the Offering.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. On July 29, 2026, the Company issued a press release, titled “Marpai. Announces $12 Million Private Placement led by Mitchell Companies.” A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.
Filed exhibits (1)
EX-99.1 (by filename) ea030013901ex99-1.htm

EX-99.1 5 ea030013901ex99-1.htm PRESS RELEASE, TITLED "MARPAI. ANNOUNCES $12 MILLION PRIVATE PLACEMENT LED BY MITCHELL COMPANIES." Exhibit 99.1 Marpai Announces $12 Million Private Placement led by Mitchell Companies Tampa, Florida - July 29, 2026 - Marpai, Inc. (“Marpai” or the “Company”) (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (“TPA”), and Pharmacy Benefit Management (“PBM”) services, today announced that it entered into securities purchase agreements with accredited investors in a private placement of newly designated convertible preferred stock. The offering was led by Mitchell Companies. The investment is intended to accelerate Marpai’s growth trajectory, strengthen its technology-enabled healthcare services platform, advance the Company’s mission of delivering smarter, more efficient healthcare administration solutions for employers, members, brokers, and healthcare partners, and strengthen Marpai’s financial position. Driving Innovation in Healthcare Administration Marpai is redefining the TPA and PBM landscapes by empowering self-funded employers to maximize plan performance, drastically reduce healthcare spend, and …

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.